CITIGROUP INC (C) Stock News

Bio Usawa, a biotechnology company focused on expanding access to biologic medicines in Africa, announced the appointment of Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors. The appointment strengthens the company's governance as it advances its mission to build sustainable biomanufacturing capabilities on the continent.

The Schall Law Firm is seeking investors who purchased Lucid Group securities between February 25, 2026 and April 13, 2026 to join a class action lawsuit alleging securities fraud. The lawsuit claims Lucid made false and misleading statements about its manufacturing capabilities and overstated business strength while suffering material impacts from supplier quality issues that disrupted vehicle deliveries.

The S&P 500 rebounded this week following news of a potential US-Iran peace deal, but remains pressed against technical resistance. The upcoming Fed meeting on Wednesday is expected to take a more hawkish stance, with inflation concerns rising beyond just oil prices. Core inflation metrics remain elevated, while the labor market shows signs of strengthening, giving the Fed room to shift focus from employment to inflation control.

SpaceX's IPO raised $75 billion with shares rising 19% on the first day, making Elon Musk the world's first trillionaire. The stock market rebounded off 50-day moving averages amid strong earnings momentum and news of a potential US-Iran peace deal that pushed oil prices lower. The S&P 500 forward earnings reached record highs, though the Magnificent-7 stocks have underperformed recently. The author predicts the June Swoon may be ending with potential for a bull market resumption.

Orange S.A. announced its intention to issue a new tranche of perpetual hybrid bonds (super-subordinated, non-callable for 7 years) in euros and launch a cash tender offer to repurchase existing hybrid obligations maturing in 2026 and 2027. The move aims to proactively manage Orange's hybrid instruments portfolio. The buyback offer closes on June 22, 2026, with results announced on June 23, 2026.

Bavarian Nordic A/S has repurchased 146,973 shares under its DKK 150 million buy-back program launched on June 2, 2026, spending approximately DKK 26.7 million at an average price of DKK 181.75 per share. The company now holds 2,884,957 treasury shares, representing 3.64% of its share capital.

Q2 2026 earnings season begins July 13th with the financial sector leading. Major banks have underperformed the S&P 500 YTD, with JPMorgan up only 0.47%, Bank of America up 2.87%, and Wells Fargo down 9.20%, while Citigroup stands out with a +20.86% gain. The sector faces uncertainty over potential fed rate hikes in H2 2026. Key upcoming earnings include Kroger and Accenture on June 18th, and Micron Technology on June 24th, with semiconductors now representing 10% of global market cap.

Progressive reported strong Q1 2026 results with 13.6% underwriting margins and 9% policy growth, but momentum is slowing. April 2026 financials showed a concerning margin decline to 9.8%, suggesting the company is prioritizing growth over profitability in a softening insurance market. With earnings forecasts declining and shares trading at a premium valuation, investors may want to wait for clearer signs of recovery.

Worldline has completed a stock consolidation on June 15, 2026, exchanging 40 old shares (€0.02 par value) for 1 new share (€0.80 par value). The operation reduces outstanding shares from 2.26 billion to 56.59 million while maintaining total capital unchanged. Mechanical adjustments were made to convertible bonds (OCEANEs), stock options, and performance/free share plans to preserve holders' rights.

Worldline has completed a 40-to-1 reverse share split, reducing outstanding shares from 2.26 billion to 56.59 million with a new par value of €0.80. The company automatically adjusted conversion ratios for convertible bonds (OCEANEs), stock options, and performance/free share allocations to preserve holder rights. Trading of new shares began on June 15, 2026 under new ISIN code FR00140182K6.

China bonds emerge as surprise haven as Iran war reshapes portfolios  Reuters

Offshore wind market indicators remain subdued in Q2 2026, but renewed focus on energy security is driving recovery prospects. Global 2030 offshore wind capacity forecasts were reduced by 11% year-on-year, though 2040 expectations were moderately raised. The industry shows signs of improvement with 15 GW expected to come online by year-end, making 2026 the second highest commissioning year on record. Geopolitical events and commodity price inflation are adding risk to the sector.

The article recommends Ethereum as a cryptocurrency with significant moonshot potential, comparing it to SpaceX's IPO valuation. With Ethereum currently trading at $1,670, the author suggests purchasing the iShares Ethereum Trust ETF (ETHA) at ~$12.50 per share as an accessible alternative. The article highlights Ethereum's 55,600% historical gains, dominance in decentralized finance, smart contract capabilities, and emerging AI infrastructure potential, with Wall Street analyst Tom Lee projecting a price target of $62,000.

ByteDance , the parent company of TikTok, is reportedly in talks with  Iluvatar CoreX and  Baidu Inc.   (NASDAQ: BIDU ) to acquire AI chips.  Iluvatar CoreX is projected to deliver at least 50,000 chips to ByteDance this year, primarily for AI inference tasks, as the company broadens the user base of its Doubao chatbot. If the deal goes through, Iluvatar CoreX would become ByteDance’s third major domestic GPU supplier, following Huawei and Cambricon , according to a Reuters report on Monday. ByteDance is also considering the use of Baidu’s Kunlunxin chips, which are already used by Tencent Holdings (OTC: TCEHY ) . These potential deals highlight the increasing success of Chinese chipmakers in providing alternatives to foreign AI chips, aligning with Beijing’s push for greater self-reliance in advanced chip technology. ByteDance did not immediately respond to Benzinga’s request for comments. data-variant="card" ... Full story available on Benzinga.com

The Kroger Co. (NYSE: KR ) will release its first quarter earnings report before the opening bell on Thursday, June 18 . Analysts expect the Cincinnati, Ohio-based grocer to report quarterly earnings of $1.59 per share, up from $1.49 per share in the year-ago period. The consensus estimate for Kroger’s quarterly revenue is $45.49 billion. It reported $45.12 billion last year, according to Benzinga Pro . On May 26, Kroger announced the retirement of Tim Massa, executive vice president and chief associate experience officer. Kroger shares fell 0.6% to close at $51.26 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let's have a look at how Benzinga's most-accurate analysts have rated the company ... Full story available on Benzinga.com

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors who purchased POET securities between April 1, 2026 and April 27, 2026 may be eligible to join the class action with a lead plaintiff deadline of June 29, 2026.

Rosen Law Firm has filed a class action lawsuit against Zillow Group on behalf of investors who purchased Class A or Class C common stock between February 11, 2025 and May 7, 2026. The lawsuit alleges that Zillow made materially false and misleading statements regarding its agreement with Redfin Corporation, mischaracterizing an acquisition as a partnership, and downplaying regulatory and antitrust risks. Investors must move the court by August 10, 2026 to serve as lead plaintiff.

Rosen Law Firm has launched an investigation into The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. The allegations claim patients have suffered and died as a result. Ensign shares fell sharply on June 8, 2026, following the report's publication.

Ascentage Pharma announced seventeen clinical updates from its core assets at the 31st European Hematology Association Congress, including eight poster presentations. Key data showed olverembatinib demonstrated deep and durable responses in chronic myeloid leukemia (CML) patients resistant to first-line therapy and robust clinical response in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Lisaftoclax showed promising efficacy in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and myeloid neoplasms, with a chemotherapy-free combination regimen yielding encouraging results in pediatric patients with relapsed/refractory Ph+ ALL.

Cathie Wood's Ark Invest added SpaceX shares to four of its six actively managed ETFs on the company's IPO day (June 12), despite being restricted from selling her existing holdings due to lockup periods. Wood purchased 325,562 shares through Ark Next Generation Internet and increased SpaceX positions in other funds, signaling confidence in the company even at its $150 opening price. The article suggests aggressive investors might follow Wood's lead, while cautious investors should wait for better entry points.

Rosen Law Firm has filed class action lawsuits against BitGo Holdings, GeneDx Holdings, and Via Transportation on behalf of investors. The BitGo lawsuit alleges that offering documents contained materially false statements regarding the company's assessment of risks posed by declining digital asset prices to its business and financial performance. Investors who purchased securities during specified periods may be eligible for compensation.

Zymeworks presented Phase 1 data for ZW191, a folate receptor alpha-targeting antibody-drug conjugate, showing a confirmed objective response rate of 78.6% in FRα-positive platinum-resistant ovarian cancer patients and 47.4% in FRα-negative patients. The drug demonstrated a favorable tolerability profile with median progression-free survival of 7.6 months across ovarian and endometrial cancer cohorts. Patient recruitment in dose optimization cohorts has been completed, supporting continued clinical development.

Latin America's fintech and consumer sectors present significant long-term growth opportunities for risk-tolerant investors, driven by low digital and fintech penetration. However, the region faces elevated political and macroeconomic risks. Companies like DLocal, Nu Holdings, and BBB Foods are positioned to capitalize on this emerging market expansion.

Iran team arrive in US for World Cup opener as the two nations reach peace deal  Reuters

Crinetics Pharmaceuticals announced positive Phase 2 trial results for atumelnant, an oral ACTH receptor antagonist for treating congenital adrenal hyperplasia (CAH). The drug demonstrated sustained androgen reductions while enabling patients to lower glucocorticoid supplementation to physiologically normal levels. Additional Phase 1b/2a data in ACTH-dependent Cushing's syndrome showed rapid cortisol reduction. The company is advancing atumelnant into late-phase clinical development with Phase 3 trials already underway.

Javice founded a startup called Frank that JPMorgan acquired in 2021 for $175 million.

Iran arrive in US for World Cup opener against New Zealand in LA  Reuters

BlackLine Board Director Mika Yamamoto sold 3,000 shares on June 5, 2026, for approximately $85,425 at $28.48 per share. The sale is consistent with her historical trading patterns and does not raise red flags, as she retained 16,692 shares. Despite a 50.8% stock decline over the past year, BlackLine reported 10% year-over-year revenue growth in Q1 and projects continued growth into Q2, suggesting the market downturn may be driven by broader software sector concerns rather than company-specific issues.

Zscaler CFO Kevin Rubin discusses the company's zero-trust security platform and its role in protecting organizations from cyber threats. The company targets $5 billion in annual recurring revenue, with growth drivers including zero-trust expansion across users, cloud, and branch networks, data security services, and emerging opportunities in agentic AI security. Rubin emphasizes that vulnerabilities are being identified at machine pace by frontier AI models, making Zscaler's approach of hiding applications behind its security cloud increasingly valuable. The company recently acquired Red Canary to enhance detection and response capabilities.

Microsoft and Amazon dominate cloud computing with Azure and AWS respectively, both investing heavily in AI infrastructure. Microsoft's Azure grew 40% last quarter with a 46% operating margin and lower valuation (23x P/E), while Amazon's AWS accelerated to 28% growth—its fastest in 15 quarters—but trades at a higher valuation (29x P/E). The analyst favors Microsoft due to superior growth relative to valuation, though both face risks from margin pressure and need to prove returns on massive AI spending.